The genetically modified mosquitoes produce female offspring that die in the larval stage
THURSDAY, Aug. 20, 2020 (HealthDay News) — Hundreds of millions of genetically modified mosquitoes will be released into the Florida Keys to test if they can help control Aedes aegypti mosquitoes that carry several deadly diseases, including Zika, dengue, chikungunya, and yellow fever.
The genetically modified mosquitoes produce female offspring that die in the larval stage. Only adult female mosquitoes bite for blood, CNN reported.
In the pilot project, more than 750 million of the genetically modified mosquitoes will be released in 2021 and 2022.
The plan just received final approval from local authorities after being approved by state and federal officials, CNN reported.
CDC: Dengue Fever Cases Expected to Rise in the United States This Summer 
Low Dengue Incidence in 2020 Due to COVID-19-Related Disruption 
4CMenB Vaccine Confers Modest Protection Against Gonorrhea in Teens 
High-Dose Omega-3 Linked to A-Fib Risk in Patients With High CVD Risk 
Organized, Biennial FIT-Based Screening Linked to Lower Colorectal Cancer Mortality 
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes 
